Syncom Formulations (India) cash flow

Latest FY26

Cash from operations: ₹58.1cr+147.8% on FY25
Capital spending: ₹11.7cr+17.2% on FY25
Free cash flow: ₹46.4cr+244.4% on FY25
Cash from financing: −₹3.0cr−₹67.9 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Adjustments to reconcile profit — non-cash items
	—	−0.9	4.8	4.7	4.5
	—	1.2	0.9	4.5	3.1
	—	0.0	0.0	0.0	−0.1
	—	−30.5	−16.9	−12.6	−13.7
Changes in working capital
	—	−21.5	−20.3	0.1	−1.7
	—	−3.0	−4.3	−27.8	−8.0
	—	−1.6	−1.2	−1.5	0.5
	—	−11.4	−11.2	−3.2	−3.7
	—	30.3	18.7	3.7	6.7
	—	0.0	−0.0	0.1	1.8
	—	15.0	1.5	−0.8	2.3
	—	2.2	0.6	1.0	−1.2
Cash from operating activities
	113	101	65.5	34.0	26.6
	—	−20.2	−27.3	−31.8	−9.4
	—	80.9	38.2	2.1	17.2
	—	22.9	14.7	8.1	6.7
	—	58.1	23.4	−6.0	10.5
Cash from investing activities
	—	11.7	10.0	8.1	20.6
	—	19.9	21.8	−4.7	0.2
	—	−19.0	13.5	86.4	−24.1
	—	−50.6	−18.2	83.0	−45.0
Cash from financing activities
	—	0.0	0.0	0.0	14.6
	—	−3.1	−67.9	−10.7	25.4
	—	1.2	0.9	4.5	3.1
	—	0.0	0.0	0.0	2.8
	—	1.2	0.9	0.6	1.0
	—	−3.0	−67.9	−14.6	35.0
	—	4.4	−62.7	62.5	0.6
	—	4.4	−62.7	62.5	0.6
	—	—	—	63.4	0.9
Reference items
	87.8	77.4	54.1	29.6	19.6
	17.6%	15.8%	11.6%	11.3%	8.8%
	46.4	46.4	13.5	−14.1	−10.1
	—	42.1	−55.3	−29.3	—
	₹0.49	₹0.49	₹0.14	−₹0.15	−₹0.11
	41.18×	—	—	—	—
	—	0.76×	0.47×	−0.24×	0.52×
	—	22.9	14.7	8.1	6.7
	—	1.2	0.9	4.5	3.1

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SYNCOMF₹20.33

Syncom Formulations (India) Limited

· Pharma & Health

₹ CrorePeersHESTERBIO NGLFINE WINDLAS JAGSNPHARMAMRUTANJAN INDOCO SAIPARENTMcap ₹1,911 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	4.5	4.7	4.8	-0.9	—
+ Finance Costs	3.1	4.5	0.9	1.2	—
+ Other Non-cash Items	-0.1	0.0	0.0	0.0	—
+ Other Reconciling Items	-13.7	-12.6	-16.9	-30.5	—
Changes in Working Capital
+ Inventories	-1.7	0.1	-20.3	-21.5	—
+ Trade Receivables — Current	-8.0	-27.8	-4.3	-3.0	—
+ Other Financial Assets — Current	0.5	-1.5	-1.2	-1.6	—
+ Other Current Assets	-3.7	-3.2	-11.2	-11.4	—
+ Trade Payables — Current	6.7	3.7	18.7	30.3	—
+ Other Financial Liabilities — Current	1.8	0.1	-0.0	0.0	—
+ Other Current Liabilities	2.3	-0.8	1.5	15.0	—
+ Provisions — Current	-1.2	1.0	0.6	2.2	—
Cash from Operating Activities
Profit Before Tax (per I/S)	26.6	34.0	65.5	101.1	113.1
+ Total Adjustments (incl. Working Capital)	-9.4	-31.8	-27.3	-20.2	—
Cash from Operations (pre-tax)	17.2	2.1	38.2	80.9	—
+ Income Taxes Paid	6.7	8.1	14.7	22.9	—
Cash from Operating Activities	10.5	-6.0	23.4	58.1	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	20.6	8.1	10.0	11.7	—
+ Acq of Investment Property	0.2	-4.7	21.8	19.9	—
+ Other Inflows / (Outflows) — Investing	-24.1	86.4	13.5	-19.0	—
Cash from Investing Activities	-45.0	83.0	-18.2	-50.6	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	14.6	0.0	0.0	0.0	—
+ Proceeds from Borrowings	25.4	-10.7	-67.9	-3.1	—
+ Interest Paid	3.1	4.5	0.9	1.2	—
+ Dividends Paid	2.8	0.0	0.0	0.0	—
+ Other Inflows / (Outflows) — Financing	1.0	0.6	0.9	1.2	—
Cash from Financing Activities	35.0	-14.6	-67.9	-3.0	—
Net Changes in Cash (pre-FX)	0.6	62.5	-62.7	4.4	—
Net Changes in Cash	0.6	62.5	-62.7	4.4	—
Closing Cash	0.9	63.4	—	—	—
Reference Items
EBITDA	19.6	29.6	54.1	77.4	87.8
EBITDA Margin %	8.75	11.26	11.64	15.83	17.64
Free Cash Flow (CFO − Capex)	-10.1	-14.1	13.5	46.4	46.4
Free Cash Flow to Equity	—	-29.3	-55.3	42.1	—
Free Cash Flow per Basic Share	-0.11	-0.15	0.14	0.49	0.49
Price to Free Cash Flow	—	—	—	—	41.18
Cash Flow to Net Income	0.52	-0.24	0.47	0.76	—
Cash Paid for Taxes	6.7	8.1	14.7	22.9	—
Cash Paid for Interest	3.1	4.5	0.9	1.2	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.